Are redox changes a critical switch for mitotic progression?

AURKA kinase activation mitosis mitotic kinase redox regulation

Journal

Molecular & cellular oncology
ISSN: 2372-3556
Titre abrégé: Mol Cell Oncol
Pays: United States
ID NLM: 101642411

Informations de publication

Date de publication:
23 Oct 2020
Historique:
entrez: 25 11 2020
pubmed: 26 11 2020
medline: 26 11 2020
Statut: epublish

Résumé

Cell-cycle dependent redox changes result in increased protein oxidation in mitotic cells. We show that oxidative modifications of a conserved cysteine residue within Aurora A kinase (AURKA) can promote its activation during mitosis. Targeting redox-sensitive cysteine residues within AURKA may lead to the development of novel anti-cancer agents with improved clinical efficacy.

Identifiants

pubmed: 33235921
doi: 10.1080/23723556.2020.1832419
pii: 1832419
pmc: PMC7670999
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1832419

Subventions

Organisme : NIEHS NIH HHS
ID : R01 ES015339
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA014051
Pays : United States
Organisme : NIEHS NIH HHS
ID : R35 ES028374
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM104047
Pays : United States
Organisme : NIEHS NIH HHS
ID : R21 ES020466
Pays : United States

Informations de copyright

© 2020 The Author(s). Published with license by Taylor & Francis Group, LLC.

Références

Proc Natl Acad Sci U S A. 2016 Nov 29;113(48):13726-13731
pubmed: 27837025
Proc Natl Acad Sci U S A. 2010 Dec 7;107(49):21022-7
pubmed: 21097701
Cell Div. 2018 Sep 19;13:7
pubmed: 30250494
Eur J Med Chem. 2017 Nov 10;140:1-19
pubmed: 28918096
Sci Signal. 2018 Aug 14;11(543):
pubmed: 30108183
Free Radic Biol Med. 2017 Feb;103:177-187
pubmed: 28017898
Redox Biol. 2020 Jan;28:101318
pubmed: 31546169
Sci Signal. 2020 Jul 07;13(639):
pubmed: 32636306
Sci Signal. 2020 Jul 21;13(641):
pubmed: 32694171
Cell Syst. 2019 Feb 27;8(2):163-167.e2
pubmed: 30797774

Auteurs

Daniel C Lim (DC)

MIT Center for Precision Cancer Medicine, Koch Institute for Integrative Cancer Research, and Departments of Biological Engineering and Biology, Massachusetts Institute of Technology, Cambridge, MA, USA.

Vladimir Joukov (V)

Department of Molecular Oncology, N. N. Petrov National Medical Research Center of Oncology, Saint Petersburg, 197758, Russian Federation.

Michael B Yaffe (MB)

MIT Center for Precision Cancer Medicine, Koch Institute for Integrative Cancer Research, and Departments of Biological Engineering and Biology, Massachusetts Institute of Technology, Cambridge, MA, USA.
Divisions of Acute Care Surgery, Trauma, and Surgical Critical Care, and Surgical Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

Classifications MeSH